Clinical Trials Update: Jan. 14, 2011
Multiple Sclerosis Ulcerative Colitis Birth Control
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study, for people being treated for relapsing multiple sclerosis, will evaluate patient satisfaction with fingolimod, compared to other MS drugs.
The research site is in Bradenton, Fla.
This 14-month study for people 18 and older will evaluate a once-daily investigational drug for ulcerative colitis.
The research site is in Sandy, Utah.
This six-month birth control study seeks healthy females who are able to make six clinic visits.
The research site is in Los Angeles, Calif.
Copyright 2011 ClinicalConnection.com. All rights reserved.